Title
Povezanost varijacija u genu za Klotho protein, parametara mineralno-koštanog metabolizma i ehokardiografskih karakteristika kod bolesnika na hemodijalizi
Creator
Apostolović, Branislav,
CONOR:
95288329
Copyright date
2022
Object Links
Select license
Autorstvo-Nekomercijalno-Bez prerade 3.0 Srbija (CC BY-NC-ND 3.0)
License description
Dozvoljavate samo preuzimanje i distribuciju dela, ako/dok se pravilno naznačava ime autora, bez ikakvih promena dela i bez prava komercijalnog korišćenja dela. Ova licenca je najstroža CC licenca. Osnovni opis Licence: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/deed.sr_LATN. Sadržaj ugovora u celini: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/legalcode.sr-Latn
Language
Serbian
Cobiss-ID
Theses Type
Doktorska disertacija
description
Datum odbrane: 23.11.2022.
Other responsibilities
Academic Expertise
Medicinske nauke
University
Univerzitet u Nišu
Faculty
Medicinski fakultet
Group
Katedra za biohemiju
Alternative title
The interrelationship between Klotho protein gene variations, mineral bone metabolism and echocardiographic characteristics in hemodialysis patients
Publisher
[B. LJ. Apostolović]
Format
152 lista
description
Biografija autora: list 151,
Bibliografija: listovi 130-150.
description
Internal medicine, biochemistry
Abstract (en)
Mineral bone metabolism disorder plays a major role in the etiopathogenesis of
cardiovascular events in hemodialysis patients. In recent years, many new
parameters associated with the homeostasis of mineral bone metabolisms, such as
fibroblast growth factor 23 (FGF23) and Klotho protein, have been discovered. The
main goal of this study is to discover interrelationships between Klotho protein gene
variations, mineral bone metabolism, and left ventricular hypertrophy (LVH) in
hemodialysis patients.
The study included 142 patients who were genotyped for G-395A and C1818T
Klotho gene polymorphism. Laboratory analyses were performed for routine
parameters of mineral bone metabolism (calcium, phosphorus, parathyroid
hormone, and alkaline phosphatase) and new parameters (FGF23, Klotho, and
vitamin D) and echocardiographic examination. Models for the determination of
predictive capabilities of Klotho gene variations and parameters of mineral bone
metabolism for the development of LVH were designed. The five-year survival rate
was monitored.
Carriers of A-allele of the G-395A Klotho gene polymorphism, compared to non-Aallele
carriers, are significantly longer on chronic hemodialysis program (p=0.033),
started renal replacement therapy at an earlier stage of life (p=0.044), have
decreased concentration of Klotho protein (p=0.01), have increased concentration of
FGF23 (p=0.031) and phosphorus (p=0.016). The best prediction for the
development of LVH was reached by adding all three new parameters of mineral
bone metabolism and Klotho G-395A polymorphism; AUC has shown significant
improvement from 0.596 to 0.806 (p< 0.001), and an improvement in patient
reclassifications for 82.1% (95% CI 42.9–121.3%). During the five-year follow-up,
the mortality rate was 52.1%, where 46.6% had cardiovascular complications as a
direct cause of death.
The G-395A Klotho polymorphism is determined due to faster progression of
chronic kidney disease in A-allele carriers, decreased concentration of Klotho
protein, and increased concentration of FGF23 and phosphorus, which suggest that
they have a higher risk for the development of cardiovascular complications. This
research has shown the prediction power of the new parameters of mineral bone
metabolism for the development of LVH and mortality. Knowledge of Klotho gene
variations contributes to the personalised management of patients, which, alongside
the application of adequate therapeutic means and procedures, increases the quality
of life and more prolonged survival of the hemodialysis patients.
Authors Key words
Klotho, FGF23, vitamin D, polimorfizam, hemodijaliza, hipertrofija leve
komore, preživljavanje
Authors Key words
Klotho, FGF23, vitamin D, polymorphism, hemodialysis, left ventricular
hypertrophy, survival
Classification
616.61+616.7:[616.71-008:577.122(043.3)
Subject
B560
Type
Tekst
Abstract (en)
Mineral bone metabolism disorder plays a major role in the etiopathogenesis of
cardiovascular events in hemodialysis patients. In recent years, many new
parameters associated with the homeostasis of mineral bone metabolisms, such as
fibroblast growth factor 23 (FGF23) and Klotho protein, have been discovered. The
main goal of this study is to discover interrelationships between Klotho protein gene
variations, mineral bone metabolism, and left ventricular hypertrophy (LVH) in
hemodialysis patients.
The study included 142 patients who were genotyped for G-395A and C1818T
Klotho gene polymorphism. Laboratory analyses were performed for routine
parameters of mineral bone metabolism (calcium, phosphorus, parathyroid
hormone, and alkaline phosphatase) and new parameters (FGF23, Klotho, and
vitamin D) and echocardiographic examination. Models for the determination of
predictive capabilities of Klotho gene variations and parameters of mineral bone
metabolism for the development of LVH were designed. The five-year survival rate
was monitored.
Carriers of A-allele of the G-395A Klotho gene polymorphism, compared to non-Aallele
carriers, are significantly longer on chronic hemodialysis program (p=0.033),
started renal replacement therapy at an earlier stage of life (p=0.044), have
decreased concentration of Klotho protein (p=0.01), have increased concentration of
FGF23 (p=0.031) and phosphorus (p=0.016). The best prediction for the
development of LVH was reached by adding all three new parameters of mineral
bone metabolism and Klotho G-395A polymorphism; AUC has shown significant
improvement from 0.596 to 0.806 (p< 0.001), and an improvement in patient
reclassifications for 82.1% (95% CI 42.9–121.3%). During the five-year follow-up,
the mortality rate was 52.1%, where 46.6% had cardiovascular complications as a
direct cause of death.
The G-395A Klotho polymorphism is determined due to faster progression of
chronic kidney disease in A-allele carriers, decreased concentration of Klotho
protein, and increased concentration of FGF23 and phosphorus, which suggest that
they have a higher risk for the development of cardiovascular complications. This
research has shown the prediction power of the new parameters of mineral bone
metabolism for the development of LVH and mortality. Knowledge of Klotho gene
variations contributes to the personalised management of patients, which, alongside
the application of adequate therapeutic means and procedures, increases the quality
of life and more prolonged survival of the hemodialysis patients.
“Data exchange” service offers individual users metadata transfer in several different formats. Citation formats are offered for transfers in texts as for the transfer into internet pages. Citation formats include permanent links that guarantee access to cited sources. For use are commonly structured metadata schemes : Dublin Core xml and ETUB-MS xml, local adaptation of international ETD-MS scheme intended for use in academic documents.